Susquehanna International Group
AVNS icon

Susquehanna International Group’s Avanos Medical AVNS Stock Holding History

Susquehanna International Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,100
Closed -$222K – 12714
2021
Q2 		$222K Buy
+6,100
New +$252K ﹤0.01% 11372
2020
Q4 		– Sell
-7,400
Closed -$246K – 10986
2020
Q3 		$246K Buy
+7,400
New +$236K ﹤0.01% 9098
2020
Q2 		– Sell
-20,700
Closed -$557K – 10099
2020
Q1 		$557K Buy
20,700
+5,900
+40% +$176K ﹤0.01% 6690
2019
Q4 		$499K Buy
14,800
+900
+6% +$32.6K ﹤0.01% 6984
2019
Q3 		$521K Sell
13,900
-1,200
-8% -$45.8K ﹤0.01% 7223
2019
Q2 		$659K Buy
15,100
+3,400
+29% +$145K ﹤0.01% 6655
2019
Q1 		$499K Sell
11,700
-4,300
-27% -$193K ﹤0.01% 6279
2018
Q4 		$717K Sell
16,000
-31,500
-66% -$1.65M ﹤0.01% 5345
2018
Q3 		$3.25M Buy
47,500
+10,300
+28% +$663K ﹤0.01% 3245
2018
Q2 		$2.13M Buy
37,200
+17,700
+91% +$935K ﹤0.01% 3907
2018
Q1 		$899K Buy
19,500
+10,800
+124% +$513K ﹤0.01% 5477
2017
Q4 		$402K Sell
8,700
-6,100
-41% -$280K ﹤0.01% 7042
2017
Q3 		$666K Sell
14,800
-15,900
-52% -$678K ﹤0.01% 6016
2017
Q2 		$1.21M Sell
30,700
-2,700
-8% -$102K ﹤0.01% 4878
2017
Q1 		$1.27M Buy
33,400
+600
+2% +$23.4K ﹤0.01% 4622
2016
Q4 		$1.21M Sell
32,800
-20,600
-39% -$736K ﹤0.01% 5108
2016
Q3 		$1.85M Sell
53,400
-21,900
-29% -$767K ﹤0.01% 3691
2016
Q2 		$2.45M Buy
75,300
+37,700
+100% +$1.15M ﹤0.01% 3239
2016
Q1 		$1.08M Sell
37,600
-9,200
-20% -$245K ﹤0.01% 4924
2015
Q4 		$1.56M Sell
46,800
-1,100
-2% -$34.2K ﹤0.01% 4542
2015
Q3 		$1.36M Buy
47,900
+13,600
+40% +$474K ﹤0.01% 5057
2015
Q2 		$1.39M Buy
34,300
+27,000
+370% +$1.21M ﹤0.01% 5488
2015
Q1 		$359K Sell
7,300
-21,200
-74% -$982K ﹤0.01% 7668
2014
Q4 		$1.29M Buy
+28,500
New +$1.12M ﹤0.01% 5356

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Susquehanna International Group's AVNS Position: Q1 2026 in Review

Susquehanna International Group increased its Avanos Medical (AVNS) stake by 11% in Q1 2026, buying an estimated $23.9K and bringing the position to 18,512 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #11183.

Susquehanna International Group first reported a position in AVNS in Q4 2014 and has held it in 30 quarters since. The position peaked at $6.59M in Q1 2015. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Susquehanna International Group held 18,512 shares of Avanos Medical worth $259K as of Q1 2026.
  • Susquehanna International Group bought 1,776 Avanos Medical shares in Q1 2026, an estimated $23.9K.
  • Avanos Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11183 holding.
  • Susquehanna International Group first reported a position in Avanos Medical in Q4 2014 and has held it in 30 quarters since.
  • Susquehanna International Group's Avanos Medical position peaked at $6.59M in Q1 2015.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.